Review





Similar Products

clinician allergan platysma prominence scale c apps  (Allergan)
86
Allergan clinician allergan platysma prominence scale c apps
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
Clinician Allergan Platysma Prominence Scale C Apps, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/pmc13049361-39-38-39?v=Allergan
Average 86 stars, based on 1 article reviews
clinician allergan platysma prominence scale c apps - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
c intranasal administration app×ps1 transgenic mice  (Jackson Laboratory)
86
Jackson Laboratory c intranasal administration app×ps1 transgenic mice
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
C Intranasal Administration App×Ps1 Transgenic Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/us12590130-500-24-35?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
c intranasal administration app×ps1 transgenic mice - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
c apps  (Allergan)
86
Allergan c apps
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
C Apps, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/10__1097_slash_prs__0000000000012629-164-0-2?v=Allergan
Average 86 stars, based on 1 article reviews
c apps - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
tough talks for covid-19 vaccine (tt-c) mobile health app-based intervention  (Virtually Better Inc)
90
Virtually Better Inc tough talks for covid-19 vaccine (tt-c) mobile health app-based intervention
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
Tough Talks For Covid 19 Vaccine (Tt C) Mobile Health App Based Intervention, supplied by Virtually Better Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/pmc12217844-141-28-22?v=Virtually+Better+Inc
Average 90 stars, based on 1 article reviews
tough talks for covid-19 vaccine (tt-c) mobile health app-based intervention - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
anti-app c-terminal  (Millipore)
90
Millipore anti-app c-terminal
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
Anti App C Terminal, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/pm40580389-89-5-9?v=Millipore
Average 90 stars, based on 1 article reviews
anti-app c-terminal - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
highthroughput sequencing primer kit (app-c)  (MGI Tech Co Ltd)
90
MGI Tech Co Ltd highthroughput sequencing primer kit (app-c)
Injection sites based on baseline Clinician Allergan Platysma <t>Prominence</t> Scale <t>(C‐APPS)</t> score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .
Highthroughput Sequencing Primer Kit (App C), supplied by MGI Tech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/app+%28c/10__3390_slash_biomedicines13040863-48-15-20?v=MGI+Tech+Co+Ltd
Average 90 stars, based on 1 article reviews
highthroughput sequencing primer kit (app-c) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Injection sites based on baseline Clinician Allergan Platysma Prominence Scale (C‐APPS) score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .

Journal: Journal of Cosmetic Dermatology

Article Title: Patient‐Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose‐Ranging Study

doi: 10.1111/jocd.70821

Figure Lengend Snippet: Injection sites based on baseline Clinician Allergan Platysma Prominence Scale (C‐APPS) score of grade 3 (left) or grade 4 (right). Reprinted with permission from Rohrich et al. .

Article Snippet: Eligible subjects were adults aged ≥ 18 years with moderate (grade 3) or severe (grade 4) PP at maximum contraction on left and right sides at screening and on day 1 as assessed by the investigator using the Clinician Allergan Platysma Prominence Scale (C‐APPS) and by the subject using the Participant Allergan Platysma Prominence Scale (P‐APPS).

Techniques: Injection

Representative images from a 42‐year‐old subject before and after treatment with onabotA. (A) Subject had grade 4 platysma prominence on both sides of the face at baseline based on the C‐APPS. (B) On day 14 after treatment with 36 U of onabotA, the subject achieved a 3‐grade improvement on the C‐APPS on both sides of the face. Reprinted with permission from Rohrich et al. . C‐APPS, Clinician Allergan Platysma Prominence Scale; onabotA, onabotulinumtoxinA.

Journal: Journal of Cosmetic Dermatology

Article Title: Patient‐Reported Outcomes After Treatment With OnabotulinumtoxinA for Platysma Prominence: Results From a Phase 2 Dose‐Ranging Study

doi: 10.1111/jocd.70821

Figure Lengend Snippet: Representative images from a 42‐year‐old subject before and after treatment with onabotA. (A) Subject had grade 4 platysma prominence on both sides of the face at baseline based on the C‐APPS. (B) On day 14 after treatment with 36 U of onabotA, the subject achieved a 3‐grade improvement on the C‐APPS on both sides of the face. Reprinted with permission from Rohrich et al. . C‐APPS, Clinician Allergan Platysma Prominence Scale; onabotA, onabotulinumtoxinA.

Article Snippet: Eligible subjects were adults aged ≥ 18 years with moderate (grade 3) or severe (grade 4) PP at maximum contraction on left and right sides at screening and on day 1 as assessed by the investigator using the Clinician Allergan Platysma Prominence Scale (C‐APPS) and by the subject using the Participant Allergan Platysma Prominence Scale (P‐APPS).

Techniques: